If we have any methods to widen CI in parallel design with high variance drug? [RSABE / ABEL]

posted by ElMaestro  – Denmark, 2021-02-02 12:12 (1172 d 04:24 ago) – Posting: # 22200
Views: 1,792

Hi libaiyi,

❝ (...) So my quesion is if we have any method to widen the CI like RSABE in cross-over study?


I don't think there is any authority generally willing to widen the acceptance range in parallel trials involving humans (they'd perhaps do it if you were studying pMDI's in vitro etc).

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,665 registered users;
85 visitors (1 registered, 84 guests [including 7 identified bots]).
Forum time: 17:37 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5